La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Movement Disorders (drug therapy) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Movement Disorders (diagnostic imaging) < Movement Disorders (drug therapy) < Movement Disorders (epidemiology)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000132 (2000) J J Ferreira [France] ; O. RascolPrevention and therapeutic strategies for levodopa-induced dyskinesias in Parkinson's disease.
000366 (2003) Entacapone/levodopa/carbidopa combination tablet: Stalevo.
000449 (????) V. Mesnage [France] ; J L Houeto ; A M Bonnet ; I. Clavier ; I. Arnulf ; F. Cattelin ; G. Le Fur ; P. Damier ; M L Welter ; Yves AgidNeurokinin B, neurotensin, and cannabinoid receptor antagonists and Parkinson disease.
001406 (2014) Franziska Richter [États-Unis] ; Fuying Gao [États-Unis] ; Vera Medvedeva [États-Unis] ; Patrick Lee [États-Unis] ; Nicholas Bove [États-Unis] ; Sheila M. Fleming [États-Unis] ; Magali Michaud [France] ; Vincent Lemesre [États-Unis] ; Stefano Patassini [États-Unis] ; Krystal De La Rosa [États-Unis] ; Caitlin K. Mulligan [États-Unis] ; Pedrom Sioshansi [États-Unis] ; Chunni Zhu [États-Unis] ; Giovanni Coppola [États-Unis] ; Thierry Bordet [France] ; Rebecca Pruss [France] ; Marie-Françoise Chesselet [États-Unis]Chronic administration of cholesterol oximes in mice increases transcription of cytoprotective genes and improves transcriptome alterations induced by alpha-synuclein overexpression in nigrostriatal dopaminergic neurons
001B45 (1989) E. Pourcher [France] ; A M Bonnet ; J. Kefalos ; B. Dubois ; Yves Agid [France]Effects of etybenzatropine and diazepam on levodopa-induced diphasic dyskinesias in Parkinson's disease.
001C38 (1987) P. Rondot [France] ; M. Ziegler ; N. Aymard ; J. HolzerClinical trial of Madopar HBS in parkinsonian patients with fluctuating drug response after long-term levodopa therapy.
001C71 (????) F. Mauguière [France] ; E. Broussolle ; J. IsnardApomorphine-induced relief of the akinetic-rigid syndrome and early median nerve somatosensory evoked potentials (SEPs) in Parkinson's disease.
001D60 (1993) O J Rascol [France] ; U. Sabatini ; F. Chollet ; J L Montastruc ; J P Marc-Vergnes ; A. RascolImpaired activity of the supplementary motor area in akinetic patients with Parkinson's disease. Improvement by the dopamine agonist apomorphine.
001D94 (1996) O. Rascol [France] ; A J Lees ; J M Senard ; Z. Pirtosek ; C. Brefel ; J L Montastruc ; D. FuellA placebo-controlled study of ropinirole, a new D2 agonist, in the treatment of motor fluctuations of L-DOPA-treated parkinsonian patients.
001E03 (1996) A F Carpentier [France] ; A M Bonnet ; M. Vidailhet ; Yves Agid [France]Improvement of levodopa-induced dyskinesia by propranolol in Parkinson's disease.
001E16 (1996) F. Picard [France] ; E. Hirsch ; E. Salmon ; C. Marescaux ; M. Collard[Parkinsonian syndrome and post-encephalitic stereotyped involuntary movements responsive to L-dopa].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Movement Disorders (drug therapy)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Movement Disorders (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Movement Disorders (drug therapy)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024